{"name":"Adverum Biotechnologies, Inc.","slug":"adverum-biotechnologies-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Ophthalmology","slug":"ophthalmology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ADVM-022","genericName":"ADVM-022","slug":"advm-022","indication":"Wet age-related macular degeneration","status":"phase_2"}]}],"pipeline":[{"name":"ADVM-022","genericName":"ADVM-022","slug":"advm-022","phase":"phase_2","mechanism":"ADVM-022 is an adeno-associated virus (AAV) vector-based gene therapy that targets the vascular endothelial growth factor A (VEGF-A) gene.","indications":["Wet age-related macular degeneration"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxONVpEUGR3R3JWdDhic2hSZkdTT2N0cU8zUVU5TjFrRmxFMFR3elJWSWduSVNkS0tnLUxSbVpIVi1MelhNSlh4cEM1YlplYTdqWWp4TnU1R0lDenJacFBXc215MnlxVlJIQkRjZC0yUWVuc2M4amdVd0pfSUk1MkEtQ1dPS2ZRZFNTU2IxX1NkWU9jQmctMHNDLVFqTE5FdE5fVW1zTFUtLW1nVDZ3VXJYS1FtWER6Qzg4d0M1UURSR3ZoTnRxVmVHV2ZOUTl0cU82dWduTzk2YjRrT0s3QWdOTQ?oc=5","date":"2026-03-26","type":"pipeline","source":"PharmiWeb.com","summary":"Faron Pharmaceuticals Ltd: Faron Appoints New CTO to Strengthen Late-Stage Development Activities - PharmiWeb.com","headline":"Faron Pharmaceuticals Ltd: Faron Appoints New CTO to Strengthen Late-Stage Development Activities","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQRmgxeE1ORWZVQVBoUlItbF9kVHZ1TEl5MFU5VVNrTUt6MFlTWnVxd3JVODNld2x5MnpwSms5aG1mV2dHRk1jandEY1drZkctbXp3ZmVjMnhDSTNYWG9nblNpQmxpdWt5cTRDSEYzN1JtaTVsNDd3RnlqdHA0bnlYQnhqYmJ2WHI2RlQxZ2ZidTBOazdPQlFtc1FBLWRLRWczRDdzLUd4TGc4Q0pM0gGzAUFVX3lxTFAxTm1TeVJ0czVaMDhsNmNqZzBVTUhMdklTdHU0OFM4aHQwN1VNbXhCZnMyVDhsNWV3SFB6cm1EMm5WWTdVUWQxaFhzdzZuQ1JaZGkzQlMtemxIZS0zaDBCMXMyRGNTNHZhY3pLM3gyTjBGWllvVVFwWlpKMVNfd2ZQWkw5bG5pUlBINFBuUTNWRnhJNEtjSjNUWi1EQTBBWDRsbktwMUFyVTNoUzBNMlZoSlY4?oc=5","date":"2025-12-10","type":"pipeline","source":"Indian Pharma Post","summary":"Lilly moves forward with $3.56-per-share acquisition of Adverum - Indian Pharma Post","headline":"Lilly moves forward with $3.56-per-share acquisition of Adverum","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPUVRQamxHVFpTYTFXWURoSV9WRmlPZjM3NmtialhoV3NhYzlIdnp6T1Z0MjJrZFluR1U4X292SDBnRmltUGM0Wk9tZ1JraVprV2FHVkhDZUcybHkyRG5PWU5BTngwR2ZOelM1U2VUWnNxMzZNMFp6dmR4djR4dXV4TERTZUMwMkMxTGdZcnVpWjhVZ0hpYUt3WQ?oc=5","date":"2025-10-27","type":"deal","source":"Contract Pharma","summary":"Lilly Agrees to Acquire Adverum Biotechnologies - Contract Pharma","headline":"Lilly Agrees to Acquire Adverum Biotechnologies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPZDNydTA4MmljWE5aYmY0aVlHSmdwb3hFbEZaR3dSRl9pOTdLVUV0VHY1anY0SmlMRXVvVl9oY3hOczZUTlU2RC1kUkRjQUl4ZTZGWkY3NnhoUTRleGd3WHdGM25yOHFaeVdJSERjSDFPRnV6ajZmaVFwMWVVOUdaSDdOZFRLTVUtMWFMemxhVkJoN3lVdkNpeUhvXzA1d21McFVKRmdR?oc=5","date":"2025-10-27","type":"deal","source":"Pharmaceutical Technology","summary":"Eli Lilly buys Adverum in eye disease gene therapy punt - Pharmaceutical Technology","headline":"Eli Lilly buys Adverum in eye disease gene therapy punt","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPSlZNRVFIbzB1dnRyN0RDUkxRcFg4UnJBOXcwS0UwNTRqcFlSOE84b0tYbTUtZzdYQ3lZNHYzTnYtOUhra2VCSEQ4Z2k4aVFiS2RkUnpCU1k1a1NtWFkzMldKb2NJcWs4TnBWV1FwX0lPb1dxNXIxcEotZXRHMXAyTmxPX21tZ245eExzU20yU2R3NzhGXzhBenpZclp3bFp0N3c?oc=5","date":"2025-10-27","type":"deal","source":"The Business Journals","summary":"Pharma giant buys firm that once had big plans for Research Triangle Park - The Business Journals","headline":"Pharma giant buys firm that once had big plans for Research Triangle Park","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-27","type":"deal","source":"Express Pharma","summary":"Eli Lilly to acquire Adverum Biotechnologies and expand gene therapy portfolio with Ixo-vec - Express Pharma","headline":"Eli Lilly to acquire Adverum Biotechnologies and expand gene therapy portfolio with Ixo-vec","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPcEFvTk5sSjJJNUxBRi1TMmtsTFlmbVhNOGlEdEp6N0VlVXJnRWpwRng3Mlp3X1VvbC05WXFBbDIwV2VnUGxBMmMyNUtzYnQ4aTNxOVlGdXJqNlFGa0ktdXBFZDNqb3ZaYVJITjh2WG0wSmpDMVVTOFAyLUhZNDRoY2RqNWt4TjhRQzRfVHpNR1AzOWZEcVNv0gGcAUFVX3lxTFBiZU0wRVJtaFk0VHNRa2E3SGZKZm1XR2I2UzFXeGFfN2ZzYXdiN0tmdVJJUUhMQmpuMmVFWW1DQVUzMnN4SXlfb1VvUEt5cG5WaEsxdjc4SVJPbGx4RnlFdlREcW9td0RYVDhUT21oY3hDazdTOVFwYWprN040dmdLWW11V0w3ZE5TSDhjZ1JxUTJSWjhHUklyb0JmZw?oc=5","date":"2025-10-26","type":"deal","source":"Medical Dialogues","summary":"Lilly to buy Adverum Biotechnologies - Medical Dialogues","headline":"Lilly to buy Adverum Biotechnologies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNN1dHQWV3NnZNT013d2g2SUxFZVNlTm1sVy1NYURRWjVyR0lQZEZjYy0ycnMwUlhYSk5BWnUtMWJVd29FVmtUMU1mS1RfVi1NNV83ZlYzekRVT2x5bzFJVklRbzNuaHN3YTFUalVPU1AzMTFLOVVjU1lyUGtKY3hkeGJINi13VGRqcU5QRGFxTmw5ZXUxbWNQOURRMFU?oc=5","date":"2025-10-24","type":"deal","source":"PR Newswire","summary":"Lilly to Acquire Adverum Biotechnologies - PR Newswire","headline":"Lilly to Acquire Adverum Biotechnologies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOMDQyb3NOY1pBdTlERzZzSWg4WW9JVm01MFl2WFdpYjRoT0lYQ2IwMlF4VTFvR0dOYWZjXzYwRWFpQlBXcUEwSVZ4OHAwMlFmZ0I3MnFhVE9WOEw3ZUQ5Ry0wdjlzZGV2NWpKWWM4bHFvejRqNTBJRzJURTZSX0ROcjRMZEZZODIzbkpkWjFXWTFueVBlUG1FODNoWG5NWDRnOXcwTw?oc=5","date":"2025-10-24","type":"deal","source":"BioPharma Dive","summary":"Adverum, hammered by gene therapy downturn, sells to Lilly in unusual deal - BioPharma Dive","headline":"Adverum, hammered by gene therapy downturn, sells to Lilly in unusual deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOTE9HWU9vZjI0SHpJR0EtUnYyX2VVUllTQnRJUXlmQ1ZidUYtcnlnNWk5LWVvQ01kMnZ4ZUlNZGdrRlhnS3pNZ0cyenV1X2dqanU3TVNXTjRhTEJLRFNZUGdmT1VKdUFjZVZMRGNRS2xUbmV0VE5rdTZfaUduUXpEb0VoYnJ1ZF9WbjJBNzhWblByZ1Q3MGZNMXh6dw?oc=5","date":"2025-10-24","type":"deal","source":"BioSpace","summary":"Lilly Dives Deeper Into Gene Therapy With up to $262M Adverum Buy - BioSpace","headline":"Lilly Dives Deeper Into Gene Therapy With up to $262M Adverum Buy","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-03","type":"pipeline","source":"simplywall.st","summary":"After losing 28% in the past year, Adverum Biotechnologies, Inc. (NASDAQ:ADVM) institutional owners must be relieved by the recent gain - simplywall.st","headline":"After losing 28% in the past year, Adverum Biotechnologies, Inc. (NASDAQ:ADVM) institutional owners must be relieved by ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPdjNTS2p1ZnRERmpxcENRS0U4RXp6dDNVMkRuajkxcmJsMVRnamkxanpVeENPcHB2MUxYckM3UHRmWFdjelZyUkgwX1BaZGlaeXBwMlpQcDNSTnZFYk10R1NFcUhIbmpMcWNPWFRNVUppZkFRdlMxcVBENDM3a3pCYnMzemR3VHVRWUsxclRzaVBRZ25yX0JiSzBHNU9hQlRzQzhvRzNn?oc=5","date":"2025-09-30","type":"pipeline","source":"Barchart.com","summary":"2 Penny Stocks That Wall Street Believes Can Soar Over 200% - Barchart.com","headline":"2 Penny Stocks That Wall Street Believes Can Soar Over 200%","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}